Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Coagulation VIIa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Coagulation VIIa. This report contains market size and forecasts of Recombinant Human Coagulation VIIa in global, including the following market information:
Global Recombinant Human Coagulation VIIa Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Human Coagulation VIIa Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Recombinant Human Coagulation VIIa companies in 2022 (%)
The global Recombinant Human Coagulation VIIa market was valued at US$ 1166.6 million in 2022 and is projected to reach US$ 1488.4 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%. In terms of type, the market share of prefilled syringe is over 78%. In the field of application, the market share of congenital hemophilia is about 65%.
We surveyed the Recombinant Human Coagulation VIIa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Coagulation VIIa Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Coagulation VIIa Market Segment Percentages, by Type, 2022 (%)
Prefilled Syringe
Vial
Global Recombinant Human Coagulation VIIa Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Coagulation VIIa Market Segment Percentages, by Application, 2022 (%)
Congenital Hemophilia
Acquired Hemophilia
Others
Global Recombinant Human Coagulation VIIa Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Human Coagulation VIIa Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Coagulation VIIa revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Coagulation VIIa revenues share in global market, 2022 (%)
Key companies Recombinant Human Coagulation VIIa sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Human Coagulation VIIa sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Coagulation VIIa, market overview.
Chapter 2: Global Recombinant Human Coagulation VIIa market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Coagulation VIIa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Coagulation VIIa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Coagulation VIIa capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Coagulation VIIa Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Coagulation VIIa Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Coagulation VIIa Overall Market Size
2.1 Global Recombinant Human Coagulation VIIa Market Size: 2022 VS 2029
2.2 Global Recombinant Human Coagulation VIIa Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Human Coagulation VIIa Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Human Coagulation VIIa Players in Global Market
3.2 Top Global Recombinant Human Coagulation VIIa Companies Ranked by Revenue
3.3 Global Recombinant Human Coagulation VIIa Revenue by Companies
3.4 Global Recombinant Human Coagulation VIIa Sales by Companies
3.5 Global Recombinant Human Coagulation VIIa Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Human Coagulation VIIa Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Human Coagulation VIIa Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Coagulation VIIa Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Coagulation VIIa Market Size Markets, 2022 & 2029
4.1.2 Prefilled Syringe
4.1.3 Vial
4.2 By Type - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Coagulation VIIa Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Human Coagulation VIIa Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Human Coagulation VIIa Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Coagulation VIIa Sales, 2018-2023
4.3.2 By Type - Global Recombinant Human Coagulation VIIa Sales, 2024-2029
4.3.3 By Type - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Human Coagulation VIIa Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Coagulation VIIa Market Size, 2022 & 2029
5.1.2 Congenital Hemophilia
5.1.3 Acquired Hemophilia
5.1.4 Others
5.2 By Application - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Coagulation VIIa Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Human Coagulation VIIa Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Human Coagulation VIIa Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Coagulation VIIa Sales, 2018-2023
5.3.2 By Application - Global Recombinant Human Coagulation VIIa Sales, 2024-2029
5.3.3 By Application - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Human Coagulation VIIa Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Human Coagulation VIIa Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Coagulation VIIa Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Human Coagulation VIIa Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Human Coagulation VIIa Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Coagulation VIIa Sales, 2018-2023
6.3.2 By Region - Global Recombinant Human Coagulation VIIa Sales, 2024-2029
6.3.3 By Region - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Human Coagulation VIIa Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Human Coagulation VIIa Sales, 2018-2029
6.4.3 US Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.4.4 Canada Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.4.5 Mexico Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Coagulation VIIa Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Human Coagulation VIIa Sales, 2018-2029
6.5.3 Germany Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.4 France Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.5 U.K. Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.6 Italy Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.7 Russia Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.5.9 Benelux Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Coagulation VIIa Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Human Coagulation VIIa Sales, 2018-2029
6.6.3 China Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.6.4 Japan Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.6.5 South Korea Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.6.7 India Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Human Coagulation VIIa Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Human Coagulation VIIa Sales, 2018-2029
6.7.3 Brazil Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.7.4 Argentina Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, 2018-2029
6.8.3 Turkey Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.8.4 Israel Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Human Coagulation VIIa Market Size, 2018-2029
6.8.6 UAE Recombinant Human Coagulation VIIa Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Major Product Offerings
7.1.4 Novo Nordisk Recombinant Human Coagulation VIIa Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 LFB SA HEMA Biologics
7.2.1 LFB SA HEMA Biologics Company Summary
7.2.2 LFB SA HEMA Biologics Business Overview
7.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Major Product Offerings
7.2.4 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales and Revenue in Global (2018-2023)
7.2.5 LFB SA HEMA Biologics Key News & Latest Developments
7.3 AryoGen Pharmed
7.3.1 AryoGen Pharmed Company Summary
7.3.2 AryoGen Pharmed Business Overview
7.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Major Product Offerings
7.3.4 AryoGen Pharmed Recombinant Human Coagulation VIIa Sales and Revenue in Global (2018-2023)
7.3.5 AryoGen Pharmed Key News & Latest Developments
7.4 GENERIUM
7.4.1 GENERIUM Company Summary
7.4.2 GENERIUM Business Overview
7.4.3 GENERIUM Recombinant Human Coagulation VIIa Major Product Offerings
7.4.4 GENERIUM Recombinant Human Coagulation VIIa Sales and Revenue in Global (2018-2023)
7.4.5 GENERIUM Key News & Latest Developments
8 Global Recombinant Human Coagulation VIIa Production Capacity, Analysis
8.1 Global Recombinant Human Coagulation VIIa Production Capacity, 2018-2029
8.2 Recombinant Human Coagulation VIIa Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Coagulation VIIa Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Coagulation VIIa Supply Chain Analysis
10.1 Recombinant Human Coagulation VIIa Industry Value Chain
10.2 Recombinant Human Coagulation VIIa Upstream Market
10.3 Recombinant Human Coagulation VIIa Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Coagulation VIIa Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Human Coagulation VIIa in Global Market
Table 2. Top Recombinant Human Coagulation VIIa Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Human Coagulation VIIa Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Human Coagulation VIIa Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Human Coagulation VIIa Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Human Coagulation VIIa Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Human Coagulation VIIa Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Human Coagulation VIIa Product Type
Table 9. List of Global Tier 1 Recombinant Human Coagulation VIIa Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Human Coagulation VIIa Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Human Coagulation VIIa Sales (K Units), 2024-2029
Table 16. By Application ? Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Human Coagulation VIIa Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Human Coagulation VIIa Sales (K Units), 2024-2029
Table 21. By Region ? Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Human Coagulation VIIa Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Human Coagulation VIIa Sales (K Units), 2024-2029
Table 26. By Country - North America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Human Coagulation VIIa Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Human Coagulation VIIa Sales, (K Units), 2024-2029
Table 30. By Country - Europe Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Human Coagulation VIIa Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Human Coagulation VIIa Sales, (K Units), 2024-2029
Table 34. By Region - Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Human Coagulation VIIa Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Human Coagulation VIIa Sales, (K Units), 2024-2029
Table 38. By Country - South America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Human Coagulation VIIa Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Human Coagulation VIIa Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, (K Units), 2024-2029
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Recombinant Human Coagulation VIIa Product Offerings
Table 48. Novo Nordisk Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. LFB SA HEMA Biologics Company Summary
Table 51. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Offerings
Table 52. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. LFB SA HEMA Biologics Key News & Latest Developments
Table 54. AryoGen Pharmed Company Summary
Table 55. AryoGen Pharmed Recombinant Human Coagulation VIIa Product Offerings
Table 56. AryoGen Pharmed Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AryoGen Pharmed Key News & Latest Developments
Table 58. GENERIUM Company Summary
Table 59. GENERIUM Recombinant Human Coagulation VIIa Product Offerings
Table 60. GENERIUM Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GENERIUM Key News & Latest Developments
Table 62. Recombinant Human Coagulation VIIa Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Recombinant Human Coagulation VIIa Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Recombinant Human Coagulation VIIa Production by Region, 2018-2023 (K Units)
Table 65. Global Recombinant Human Coagulation VIIa Production by Region, 2024-2029 (K Units)
Table 66. Recombinant Human Coagulation VIIa Market Opportunities & Trends in Global Market
Table 67. Recombinant Human Coagulation VIIa Market Drivers in Global Market
Table 68. Recombinant Human Coagulation VIIa Market Restraints in Global Market
Table 69. Recombinant Human Coagulation VIIa Raw Materials
Table 70. Recombinant Human Coagulation VIIa Raw Materials Suppliers in Global Market
Table 71. Typical Recombinant Human Coagulation VIIa Downstream
Table 72. Recombinant Human Coagulation VIIa Downstream Clients in Global Market
Table 73. Recombinant Human Coagulation VIIa Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Human Coagulation VIIa Segment by Type in 2022
Figure 2. Recombinant Human Coagulation VIIa Segment by Application in 2022
Figure 3. Global Recombinant Human Coagulation VIIa Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Coagulation VIIa Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Human Coagulation VIIa Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Human Coagulation VIIa Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Coagulation VIIa Revenue in 2022
Figure 9. By Type - Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Human Coagulation VIIa Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Human Coagulation VIIa Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 23. US Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 37. China Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Human Coagulation VIIa Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Human Coagulation VIIa by Region, 2022 VS 2029
Figure 54. Recombinant Human Coagulation VIIa Industry Value Chain
Figure 55. Marketing Channels
